Taurine / LDH Cancer Research Results

Taur, Taurine: Click to Expand ⟱
Features:
Taurine (2-aminoethanesulfonic acid) is a sulfur-containing “amino acid–like” molecule (not incorporated into proteins). It’s abundant in many tissues and is best thought of as a homeostatic modulator rather than a direct cytotoxin.
Core biology themes:
-Osmoregulation / membrane stabilization
-Mitochondrial support + anti-oxidant tone (indirect)
-Calcium handling modulation
-Anti-inflammatory signaling (context-dependent)
-Bile acid conjugation (tauroursodeoxycholic-type physiology, but taurine itself is a conjugating substrate)

Cancer relevance (preclinical/adjunct framing):
-Often discussed as protective (normal-tissue protection) and stress-modulating, not a primary anti-cancer agent.
-May influence redox balance, ER stress, and inflammation, which can indirectly affect tumor biology or therapy tolerance (model-dependent).
-ROS axis: tends to reduce oxidative injury (indirect)
-NRF2: sometimes reported as part of antioxidant adaptation, but not a “core direct target”
Amino acid that benefits the heart, brain and immune system.

Taurine, an organic compound containing sulfur in its chemical structure, possesses anti-inflammatory, anti-oxidant, and various physiological functions within the cardiovascular, kidney, endocrine, and immune systems.
Also an LDH inhibitor
-Neuroprotection: helps protect neurons against excitotoxicity (e.g., glutamate damage) and ROS stress.
-Anti-oxidative action:	scavenges ROS, reducing oxidative stress seen in AD brains.
-Anti-inflammatory	
-Calcium homeostasis	Helps maintain intracellular calcium balance, disrupted in AD.
-Amyloid-beta toxicity	May reduce Aβ-induced neurotoxicity and cell death in vitro.
-Tau pathology: possible reduction of tau hyperphosphorylation.
-Memory and cognition may improve learning and memory.

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Cellular osmolyte / membrane stabilization Stress tolerance modulation (context-dependent) Osmoregulation ↑; membrane stability ↑ P, R Homeostatic buffering Taurine is a major organic osmolyte; stabilizes membranes and can reduce stress-induced damage.
2 Redox tone modulation (indirect antioxidant) Oxidative stress ↓ (reported in some models) Oxidative injury ↓ (common in injury models) R, G Redox buffering Taurine is not a classic radical scavenger like polyphenols; benefits are often indirect (mitochondrial + inflammation effects).
3 Anti-inflammatory signaling (NF-κB / cytokine tone) Inflammatory tumor-support signaling ↓ (reported; model-dependent) Inflammation tone ↓ R, G Anti-inflammatory modulation Often reported to reduce pro-inflammatory cytokines and NF-κB-linked outputs in stress/injury contexts.
4 Mitochondrial function / bioenergetic stability Mitochondrial stress ↓ (context) ΔΨm stability ↑; mitochondrial resilience ↑ R, G Organelle protection Commonly framed as improving mitochondrial resilience under stress (ischemia/toxicity models); cancer direction is context-dependent.
5 Calcium handling (Ca2+ homeostasis) Stress signaling modulation (context) Ca2+ buffering / excitability modulation P, R Signal stabilization Taurine is often described as modulating Ca2+ fluxes and reducing Ca2+-overload injury.
6 ER stress / UPR modulation ER stress ↓ (reported in some systems) Proteostasis protection ↑ R, G Proteotoxic stress buffering Reported to blunt ER-stress signaling in some injury models; cancer relevance depends on whether ER stress is pro-death or pro-survival in that tumor.
7 Apoptosis modulation (context-dependent) Apoptosis ↑ or ↓ depending on model Often anti-apoptotic under toxic stress G Cell-fate modulation Most consistent pattern is protection in normal tissues; direct tumor-killing is not a dominant taurine signature.
8 Bile acid conjugation / metabolic handling Indirect systemic metabolism effects Bile acid conjugation ↑; lipid handling modulation G Systemic metabolic support Taurine is used for bile acid conjugation; may affect gut-liver signaling indirectly.
9 Chemo-/radioprotection signals (adjunct angle) Could reduce oxidative injury (might reduce efficacy for ROS-driven modalities) Normal tissue protection potential G Supportive-care relevance If positioned, best framed as “supportive/normal-tissue buffering” and kept separate from “tumor kill” claims.
10 Translation constraint (not a primary anti-cancer agent) Direct anti-tumor efficacy is inconsistent / model-dependent Generally well-tolerated in typical dietary ranges — Expectation management Best classified as a homeostasis modulator; cancer claims should be qualified and tied to specific models.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (osmolyte + membrane/Ca2+ effects begin)
  • R: 30 min–3 hr (inflammation/redox/ER-stress signaling shifts)
  • G: >3 hr (phenotype outcomes: resilience, apoptosis modulation)


Alzheimer’s Disease (AD)-Oriented Time-Scale Flagged Pathway Table
Rank Pathway / Axis AD / Brain Context TSF Primary Effect Notes / Interpretation
1 Neuroinflammation (microglia / cytokine tone) Inflammatory signaling ↓ (reported in neuroinflammation models) R, G Anti-inflammatory modulation Taurine and taurine-derived signals are often discussed as dampening pro-inflammatory cytokine output; relevance is strongest where inflammation drives synaptic dysfunction.
2 Oxidative stress / redox buffering ROS injury ↓; lipid peroxidation ↓ (reported) R, G Neuroprotection (stress buffering) Taurine is not a classic polyphenol antioxidant; protective effects are typically indirect (mitochondrial stabilization, inflammation reduction).
3 Mitochondrial function / energy stability ΔΨm stability ↑; mitochondrial stress ↓ (reported) R, G Bioenergetic support AD is associated with mitochondrial dysfunction; taurine is often positioned as improving resilience under metabolic/oxidative stress.
4 Calcium handling / excitotoxicity buffering Ca2+ dysregulation ↓; excitotoxic pressure ↓ (reported) P, R Signal stabilization Taurine is frequently described as modulating Ca2+ flux and reducing Ca2+-overload injury, which can be relevant to excitotoxic synapse loss.
5 Osmoregulation / membrane stabilization Cell volume + membrane stability ↑ P, R Cellular resilience As a major osmolyte, taurine can stabilize membranes and reduce stress-induced injury in neurons and glia.
6 ER stress / UPR modulation ER stress ↓; proteostasis pressure ↓ (reported) R, G Proteostasis support Protein-misfolding/UPR burden is relevant in neurodegeneration; taurine is reported to buffer ER stress in several injury models.
7 Synaptic function support (neurotransmission tone) Synaptic resilience ↑ (reported) G Functional support Taurine can act as a neuromodulator (inhibitory tone) and may support synaptic stability indirectly via reduced inflammation/oxidative stress.
8 Aβ / Tau pathology (direct effects) Mixed / limited direct evidence; indirect effects via inflammation/redox more plausible G Downstream pathology modulation (uncertain) If included, keep conservative: taurine is more strongly supported as a stress-buffering agent than a direct anti-amyloid or anti-tau drug.
9 BBB / CNS exposure CNS availability depends on transport; dietary taurine raises systemic levels R PK constraint Taurine is abundant in brain but transport and distribution still matter; effects depend on achievable CNS shifts.
10 Translation constraint (adjunct positioning) Supportive neuroprotection likely; disease-modifying AD benefit not established — Expectation management Best positioned as neuroprotective / resilience-supporting; avoid claiming proven disease modification without trial-level support.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (membrane/osmolyte + Ca2+ signaling effects)
  • R: 30 min–3 hr (inflammation, mitochondrial/redox, ER-stress signaling shifts)
  • G: >3 hr (synaptic/phenotype outcomes; longer-term pathology effects if any)
LDH, Lactate Dehydrogenase: Click to Expand ⟱
Source:
Type:
LDH is a general term that refers to the enzyme that catalyzes the interconversion of lactate and pyruvate. LDH is a tetrameric enzyme, meaning it is composed of four subunits.
LDH refers to the enzyme as a whole, while LDHA specifically refers to the M subunit. Elevated LDHA levels are often associated with poor prognosis and aggressive tumor behavior, similar to elevated LDH levels.
leakage of LDH is a well-known indicator of cell membrane integrity and cell viability [35]. LDH leakage results from the breakdown of the plasma membrane and alterations in membrane permeability, and is widely used as a cytotoxicity endpoint.

However, it's worth noting that some studies have shown that LDHA is a more specific and sensitive biomarker for cancer than total LDH, as it is more closely associated with the Warburg effect and cancer metabolism.

Dysregulated LDH activity contributes significantly to cancer development, promoting the Warburg effect (Chen et al., 2007), which involves increased glucose uptake and lactate production, even in the presence of oxygen, to meet the energy demands of rapidly proliferating cancer cells (Warburg and Minami, 1923; Dai et al., 2016b). LDHA overexpression favors pyruvate to lactate conversion, leading to tumor microenvironment acidification and aiding cancer progression and metastasis.

Inhibitors:
Flavonoids, a group of polyphenols abundant in fruit, vegetables, and medicinal plants, function as LDH inhibitors.
LDH is used as a clinical biomarker for Synthetic liver function, nutrition

Tier A — Direct LDH Enzyme Inhibitors (Validated Catalytic Inhibition)

Rank Compound Type LDH Target Potency Level Primary Effect Notes
1 NCI-006 Research drug LDHA / LDHB High (in vivo active) Potent glycolysis suppression Modern benchmark LDH inhibitor used in metabolic oncology models.
2 (R)-GNE-140 Research drug LDHA (±LDHB) High (nM range reported) Lactate production ↓ Widely used experimental LDH inhibitor.
3 FX11 Research drug LDHA High (μM range) Metabolic crisis in LDHA-dependent tumors Classic LDHA inhibitor; often increases ROS secondary to metabolic stress.
4 Oxamate Tool compound LDH (pyruvate-competitive) Moderate (mM cellular use) Reduces lactate flux Classical LDH inhibitor; requires high concentrations in cells.
5 Gossypol Natural product derivative LDHA Moderate–High Glycolysis inhibition Also has other targets; safety considerations apply.
6 Galloflavin Natural compound LDH isoforms Moderate Lactate production ↓ One of the better-supported “natural-like” LDH inhibitors.

Tier B — Indirect LDH-Axis Modulators (Glycolysis / Lactate Reduction Without Confirmed Direct Catalytic Inhibition)

Rank Compound Mechanism Type LDH Claim Type Primary Axis Notes / Caution
1 Lonidamine MCT/MPC modulation Lactate axis inhibition Metabolic transport blockade Better classified as lactate/pyruvate transport modulator.
2 Stiripentol Repurposed drug LDH pathway modulation Metabolic axis modulation Emerging oncology interest; primarily neurological drug.
3 Quercetin Flavonoid Reported LDH inhibition (mixed evidence) NF-κB / PI3K modulation Often LDH-release confusion; direct enzymatic proof limited.
4 Ursolic acid Triterpenoid Reported LDH interaction Warburg modulation More credible as metabolic signaling modulator.
5 Fisetin Flavonoid Docking / indirect reports Apoptosis / survival signaling Enzyme inhibition not well validated.
6 Resveratrol Polyphenol Indirect glycolysis suppression AMPK / HIF-1α modulation Reduces lactate via upstream signaling.
7 Curcumin Polyphenol Indirect LDH expression modulation Inflammation + metabolic signaling Bioavailability limits translational strength.
8 Berberine Alkaloid Indirect metabolic modulation AMPK activation Closer to metformin-like metabolic pressure.
9 Honokiol Lignan Indirect glycolysis effects Survival pathway suppression Not validated as catalytic LDH inhibitor.
10 Silibinin Flavonolignan Mixed / indirect reports Inflammation + metabolic axis Often misclassified as LDH inhibitor.
11 Kaempferol Flavonoid Often LDH-release marker confusion Glucose transport / signaling Do not list as direct LDH inhibitor without enzyme data.
12 Oleanolic acid / Limonin / Allicin / Taurine Natural compounds Weak / indirect evidence General metabolic modulation Should not be categorized as true LDH inhibitors.

Tier A = Direct catalytic LDH inhibition (enzyme-level validation).
Tier B = Indirect lactate reduction or glycolytic modulation without strong catalytic inhibition evidence.
Important: LDH release assays (cell damage marker) are not proof of LDH enzymatic inhibition.



Scientific Papers found: Click to Expand⟱
3955- Taur,    Mechanism of neuroprotective function of taurine
- in-vitro, NA, NA
*Ca+2↓, *MMP↑, *Apoptosis↓, *Bcl-2↑, *cal2↓, *LDH↓,
3953- Taur,    Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons
- in-vitro, AD, NA
*neuroP↑, *Ca+2↓, *LDH↓,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Mitochondria & Bioenergetics ⓘ

MMP↑, 1,  

Core Metabolism/Glycolysis ⓘ

LDH↓, 2,  

Cell Death ⓘ

Apoptosis↓, 1,   Bcl-2↑, 1,  

Migration ⓘ

Ca+2↓, 2,   cal2↓, 1,  

Clinical Biomarkers ⓘ

LDH↓, 2,  

Functional Outcomes ⓘ

neuroP↑, 1,  
Total Targets: 8

Scientific Paper Hit Count for: LDH, Lactate Dehydrogenase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:158  Target#:906  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page